Healthy Fecal Microbiota Suspension Lab-Scale Production Service

Advanced Fecal Microbiota Solutions for Reproducible Preclinical Studies

FMT and live biotherapeutics research teams depend on more than access to donor material. Differences in donor health status, collection timing, oxygen exposure, solids removal, concentration, and freeze-thaw handling can shift microbial viability and composition before an animal receives the first dose. These variables can obscure biological effects and make cross-cohort comparisons difficult. Without traceable controls, an apparent treatment signal may instead reflect a preparation-related shift in the administered microbial community.

Preclinical animal platforms and translational microbiome programs therefore need a production partner that can turn complex starting material into a consistent, documented research input. Creative Biolabs provides healthy fecal microbiota suspension lab-scale production with animal-specific planning, controlled processing, fit-for-purpose testing, and delivery formats aligned with the intended route of administration.

A controlled suspension program links donor attributes, processing parameters, quality results, aliquot identity, and shipping conditions so experimental outcomes can be interpreted against a traceable production history.

Healthy Fecal Microbiota Suspension Production Services

Our service is designed around the biological material, the recipient species, and the study objective. We establish a practical production specification before processing begins, then connect each unit operation to a defined quality or usability decision.

01 / SOURCE

Donor and Raw Material Standards

Species, colony status, health criteria, sampling window, pooling strategy, exclusion criteria, and material acceptance are documented before production.

02 / CONTROL

Anaerobic and Aseptic Handling

Collection-to-processing time, atmosphere, temperature, sterile materials, and contamination controls are aligned to preserve oxygen-sensitive organisms.

03 / PROCESS

Homogenization, Filtration, and Concentration

Diluent, stool-to-buffer ratio, mixing, filtration, optional concentration, target load, and fill volume are selected for the study design.

04 / RELEASE

QC, Storage, and Batch Delivery

Viability, microbial load, composition, contamination status, cryopreservation, labeling, shipping, and batch documentation support repeatable dosing.

Service Details

Donor Selection and Characterization (Animal Specific)

Species-Specific Donor Planning

Donors may be sourced from mice, rats, pigs, or other research animals according to the approved study plan. Colony status, including specific pathogen-free or germ-free origin where required, is considered together with age, sex, diet, housing, and recent interventions.

Individual or pooled donor strategies

Health and treatment-history criteria

Collection acceptance and rejection rules

Microbiota Profiling and Baseline Definition

Donor fecal microbiota can be characterized using 16S rRNA gene sequencing, metagenomic methods, culture-based analysis, or a project-specific combination. Results help define baseline diversity, relative abundance of selected taxa, and donor-to-batch comparability.

Taxonomic composition and diversity summaries

Target or exclusion organism review

Linkage of donor profile to production batch records

Fecal Microbiota Processing (Animal Focused)

1. Standardized Collection

Collection containers, temperature controls, maximum hold time, material mass, and chain-of-custody records are defined to reduce pre-processing variation.

2. Controlled Suspension Preparation

Dilution, homogenization, filtration, optional centrifugation, concentration adjustment, and aliquoting are standardized. Anaerobic conditions can be maintained where preservation of obligate anaerobes is important.

3. Animal-Relevant Quality Control

Testing may include microbial load, CFU or viability assessment, compositional analysis, and absence testing for relevant animal pathogens or specified contaminants.

4. Cryopreservation and Storage

Appropriate cryoprotectants, fill volumes, freezing conditions, ultra-low-temperature storage, thawing instructions, and transport configurations are selected to protect the intended product profile.

Additional Services for Study-Specific Suspension Design

Customized Suspension Preparation

Production can be adapted around specific bacterial groups, defined diversity targets, donor pooling, fresh or frozen format, dosing concentration, recipient species, study length, and administration route. Feasibility is reviewed before specifications are finalized.

Microbiota Data Analysis Assistance

Optional analysis can connect donor, suspension, and post-administration microbiota data. Outputs may include diversity comparisons, taxonomic summaries, batch-to-batch assessments, and interpretation aligned with experimental endpoints.

Estimated Production Timeframe

4-8

weeks

Project timelines typically range from four to eight weeks, contingent on donor availability, processing complexity, profiling scope, custom formulation work, and QC stringency.

Specification and donor plan confirmed before production

Schedule adjusted for fresh collections or pooled batches

QC and documentation milestones agreed at project initiation

Healthy Fecal Microbiota Suspension Production Workflow

The workflow translates the supplied five-stage process into controlled decision points, from donor qualification through traceable batch delivery.

01

Donor Screening and Qualification

Confirm species, colony status, health history, exclusion criteria, and an optimal microbial profile for the research objective.

02

Stool Sample Collection and Processing

Control collection time, atmosphere, dilution, homogenization, filtration, concentration, and aliquoting to produce a uniform suspension.

03

Quality Control

Assess microbial load and viability, confirm composition where specified, review contamination controls, and verify batch acceptance.

04

Cryopreservation and Storage

Select cryoprotectant and fill format, apply controlled freezing, and maintain ultra-low-temperature storage with traceable inventory.

05

Packaging and Delivery

Aseptically package labeled aliquots, assemble batch documents, and ship under defined conditions for safe research-use delivery.

Fecal Microbiota Suspension Production Deliverables and Documentation

The final deliverable is a viable, standardized, and well-characterized fecal microbiota suspension supplied in an animal-study-ready format with documentation that supports handling, dosing, and batch traceability.

Items	Contents
Fecal Microbiota Suspension Product	A liquid or frozen suspension containing a defined community of microorganisms sourced from qualified healthy animal donors. The format can support reliable administration by oral gavage, enema, or another study-appropriate route.
Certificate of Analysis	A report summarizing agreed quality results, which may include microbial viability, load, composition or relative abundance of selected taxa, and safety-related absence testing for specified pathogens or contaminants.
Batch and Traceability Package	Donor or pool linkage, material identifiers, production date, key process parameters, aliquot count, storage status, and release disposition compiled for each small-scale batch.
Storage and Handling Instructions	Guidance for receipt, storage, thawing, mixing, hold time, and handling designed to protect the suspension profile and support consistent downstream administration.

Preclinical Applications of Healthy Fecal Microbiota Suspensions

Standardized suspensions provide a controlled input for research questions that depend on the transfer, restoration, or perturbation of complex microbial communities.

Gut Microbiota Research

Investigate how gut microbiota influence animal health, disease, host physiology, barrier function, metabolism, and host-microbe interactions.

Disease Modeling and Therapeutics

Develop dysbiosis-related animal models and evaluate FMT or microbiome-targeted approaches in inflammatory, metabolic, neurological, and other research settings.

Drug Development

Assess drug-microbiome interactions, explore microbiome-based therapeutic hypotheses, and compare how administration strategies influence microbial composition.

Nutrition and Feed Studies

Evaluate feed formulations, prebiotics, probiotics, gut health, performance outcomes, and microbiome contributions to livestock research.

Immunology and Infectious Disease

Study immune development, susceptibility to infection, colonization resistance, inflammatory responses, and microbiome-related effects on vaccine research.

Toxicology

Examine how toxicants affect microbiome composition, microbial viability, metabolic potential, and microbiota-associated host responses.

Published Data on Fecal Suspension Processing and Microbial Viability

Recently published research directly compared filtration and multiple centrifugation conditions during fecal microbiota suspension preparation. Live/dead staining and colony-forming-unit enumeration showed that filtration alone retained the highest cultivable counts and the lowest estimated mortality, while mortality increased as centrifugation force rose. The published data indicate that a processing step used to remove debris or concentrate bacteria can also change the viable community delivered to a study.

This evidence matters for preclinical production because filtration material, pore size, centrifugation strategy, temperature, and target concentration must be selected together rather than treated as interchangeable laboratory details. Creative Biolabs can translate a program's recipient species, route, dose format, and analytical priorities into a documented small-scale process with defined checkpoints for viability, load, composition, and contaminants. This supports more interpretable batch comparisons and helps teams distinguish biological study effects from preparation-related variability.

Live-dead staining and cultivable counts across fecal suspension processing groups. (OA Literature) — Fig.1 Assessment of fecal microbiota viability by LIVE/DEAD staining and CFU enumeration. ^1,2

Why Creative Biolabs for Fecal Microbiota Suspension Production

We connect starting-material control, process discipline, analytical visibility, and study-ready delivery so research teams receive a usable suspension rather than an incompletely characterized slurry.

High-Quality Starting Material

Carefully qualified healthy donors support a rich, relevant microbial community and clear source documentation.

Optimized Processing Protocols

Controlled collection, anaerobic handling, homogenization, filtration, and freezing help preserve viability and diversity.

Stringent Quality Control

Microbial viability, load, molecular profiling, and contamination testing are configured for the project.

Customizable Solutions

Donor criteria, suspension composition, processing parameters, fill format, testing, and documentation can be tailored.

Reliable Supply

Standardized small-scale batches, traceable aliquots, and defined delivery conditions support planned animal studies.

Creative Biolabs aims to supply robust, customizable fecal microbiota suspensions for research use. We prioritize quality, traceability, and collaborative study design from the first production specification through final batch delivery.

Recommended Services for FMT and Microbiome Research Programs

Extend suspension production with integrated lab-scale manufacturing, preclinical FMT research, contaminant monitoring, and stability support.

Lab-Scale Production Services Revolutionizing Therapeutic Frontiers: Comprehensive Preclinical Faecal Microbiota Transplant (FMT) Research Microbial Contaminant Monitoring Service Stability Test Services for Live Biotherapeutic Products

Customer Reviews

"The detailed Certificate of Analysis and the consistent quality of Creative Biolabs' Fecal Microbiota Suspension have greatly facilitated our drug discovery efforts."

[01/2025] S**a Williams

Frequently Asked Questions

Depending on the study objective, characterization may include aerobic and anaerobic culture, 16S rRNA gene sequencing, metagenomic profiling, microbial load measurements, and viability assays. The panel is selected to describe the suspension attributes needed for batch acceptance and downstream interpretation.

Viability can be assessed using colony-forming-unit counting, flow cytometry with membrane-integrity staining, or other fit-for-purpose approaches. Because no single method captures every member of a complex community, we align the readout with the taxa and decisions most important to the study.

Oral gavage and enema are common research routes, but the appropriate format, volume, concentration, schedule, and handling procedure depend on the recipient species and study design. Our team can help align suspension packaging and use instructions with the planned administration approach.

Yes, feasibility permitting. We can discuss donor selection, pooling, enrichment or exclusion priorities, defined bacterial groups, diversity profiles, target load, and analytical confirmation. The final specification is based on available source material and the intended experimental objective.

Other Resources

Creative Biolabs Live Biotherapeutics service brochure cover (Creative Biolabs Original)

Creative Biolabs' Live Biotherapeutics - Brochure

Probiotic strain product brochure for microbiome research (Creative Biolabs Original)

Probiotic Strain Products for NGP Research - Brochure

Small-scale microbial production brochure cover (Creative Biolabs Original)

Custom Small-Scale Probiotic Production - Brochure

Live biotherapeutics research video preview (Creative Biolabs Original)

Live Biotherapeutics - Creative Biolabs - Video

References

Liu, Yuchi, et al. "The effects of filtration and centrifugation on the gut microbiota in fecal microbiota transplantation preparation." Frontiers in Microbiology 17 (2026): 1768356.
https://doi.org/10.3389/fmicb.2026.1768356
Distributed under Open Access license CC BY 4.0, without modification.